IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Ohio

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Ohio  $ 14,680,074.39
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
ABT Holding Company (a subsidiary of Athersys Inc) MultiStem IV to treat multiple diseases involving acute tissue damage & chronic inflammation $ 244,479.24  
ABT Holding Company (a subsidiary of Athersys, Inc) Development of proprietary pharmaceutical products for the treatment of obesity by ABT $ 244,479.24  
ABT Holding Company (a subsidiary of Athersys, Inc) MultiStem-LD for treatment of AMI (heart attack) and other forms of cardiovascular disease $ 244,479.24  
Airway Therapeutics Development of Surfactant Protein-D to Prevent Occurrence of Bronchopulmonary Dysplasia $ 1,338.50 $ 69,736.00
Akebia Therapeutics, Inc. AKB-6548 for anemia associated with chronic kidney disease $ 244,479.24  
Akebia Therapeutics, Inc. AKB-9778 for vascular leak $ 244,479.24  
Akebia Therapeutics, Inc. AKB-4924 for serious infections and post-surgery wound healing $ 216,473.50 $ 28,005.74
AnalizaDx, LLC PSA/SIA  A new test for improved diagonsis of Prostate cancer $ 244,479.24  
ApneiCare, LLC Patient Study $ 116,000.00 $ 108,000.00
Arteriocyte Medical Systems, Inc. Development of Rapid, Point of Care Stem Cell Therapeutics $ 216,663.88 $ 27,815.36
Arteriocyte, Inc Advanced Stem Cell Based Cancer Diagnostics and Drug Discovery $ 65,810.00 $ 178,669.24
Arteriocyte, Inc Nanomaterials Based Production System for Therapeutic Stem Cells   $ 239,575.00
AssureRx Health, Inc. GeneSightRx Psychiatric Pharmacogenetics Product and Clinical Development $ 244,479.25  
AtriCure, Inc AtriClip Left Appendage Exclusion Clip Development and Associated EXCLUDE Clinical Trial $ 244,479.25  
AtriCure, Inc. Synergy RF Ablation Development and Associated ABLATE clinical Trial $ 244,479.25  
AXIOMED SPINE CORPORATION FREEDOM ® LIMBAR DISC $ 244,479.25  
Bionix Development Corporation Development of a Neonatal Lighted Endotracheal tube Stylet $ 7,020.16 $ 59,451.79
Bionix Development Corporation Development of a Non-Contact Electrocardiogram Monitoring Pad for Infants   $ 31,172.95
Bionix Development Corporation Development of ThermoBrachytherapy Surface applicators for Treating Cancer $ 39,398.45 $ 33,460.80
Blue Ash Therapeutics, LLC Azimilide-A Late Phase III Approvable Ventricular Antiarrhythmic   $ 244,479.25
CardioInsight Technologies, Inc CardioInsight Electrocardiograph Mapping System $ 244,479.25  
Cardiox Corporation Stroke Prevention through Development of Non-Invasive Method for Detection of Cardiac Shunts $ 244,479.25  
Cervilenz Inc Cervilenz $ 244,479.25  
ChanRx Corporation Vanoxerine Development $ 76,000.00 $ 168,479.24
Checkpoint Surgical, LLC Surgical instruments for evaluating nerve integrity   $ 244,479.25
Cleveland Medical Devices, Inc. Movement Disorders Diagnostics $ 44,197.00 $ 52,573.00
Consolidated Research of Richmond, Inc Zmachine for Chronic Insomnia $ 162,575.00 $ 81,904.24
Copernicus Therapeutics, Inc Cystic Fibrosis Therapeutic $ 118,458.00 $ 126,021.25
Copernicus Therapeutics, Inc Retinitis Pigmentosa (RP) Treatment $ 244,479.25  
Copernicus Therapeutics, Inc. Parkinson's Diseases Therapeutic $ 28,348.00 $ 177,412.50
Dermatopathology Laboratory of Central States Advancing molecular probes for melanoma diagnosis   $ 186,000.00
Estrocept Diagnostics, Inc Estrocept Breast Cancer Test   $ 55,000.00
EXCMR Ltd Exercise stress cardiac magnetic resonance imaging $ 27,391.88 $ 217,087.37
Frantz Medical Development, Ltd. Miniaturized Distal Vibration System for Penetrating Vascular Occlusions $ 193,725.00 $ 50,754.25
Great Lakes Pharmaceuticals Inc Development of B-Lock, an anti-biofilm catheter lock solution   $ 244,479.25
Imalux Corporation Optical coherence tomography:use for preinvasive and invasive epithelial cancer   $ 244,479.24
Jagle Biopharma LLC Formulation Development   $ 35,000.00
Juventas Therapeutics Inc JVS-100 for Treatment of Chronic Heart Failure $ 244,479.25  
Juventas Therapeutics Inc JVS-100 for Treatment of Critical Limb Ischemia $ 110,013.50 $ 134,465.75
Leadscope, Inc Creation of molecular feature-based QSAR toxicity prediction models. $ 244,479.24  
m2m Imaging Corporation Cryogenic MRI Coil Project $ 168,994.74 $ 50,380.09
Metallopharm LLC Catalytic Metallodrugs $ 51,492.50 $ 127,000.00
MetaMol Theranostics LLC Diagnostics and Therapies for Cancer Metastasis $ 59,767.11 $ 38,625.00
NDI Medical LLC Therapeutic relief of post-amputation pain   $ 244,479.25
NEO PROTEOMICS, INC. Drug development for Serotonin Receptors   $ 150,000.00
Neoprobe Corporation Lymphoseek $ 244,479.24  
Neuros Medical, Inc Peripheral Nerve Block Stimulation for Residual Limb Pain $ 83,245.93 $ 161,233.31
NeuroWave Systems Inc NeuroSENSE Monitor $ 15,758.50 $ 63,400.50
NovelMed Therapeutics, Inc Humanized YalcioMab for Rheumatoid Arthritis $ 244,479.24  
Optimum Therapeutics, LLC Tumor-penetrating microparticles for treating peritoneal cancers $ 89,823.77 $ 65,105.67
Optimum Therapeutics, LLC Development of siRNA cancer therapeutics $ 87,375.47 $ 56,021.15
Optimum Therapeutics, LLC Instantaneous-release paclitaxel gelatin nanoparticles for treating superficial bladder cancer $ 87,107.80 $ 157,371.45
Optimum Therapeutics, LLC Clinical Development of suramin as a nontoxic chemosensitizer for treating advanced cancer $ 157,755.83 $ 86,723.42
OtoSonics Inc. ConfirMEE - Ear Effusion Detection and Characterization System $ 244,479.25  
Percuvision, LLC Visually Guided Catheter $ 244,479.25  
Peritec Biosciences Ltd Commercialization of Tissue Lined for Stent for Peripheral Arterial Disease $ 244,479.25  
PneumoSonics Inc PneumoScan-Non-Invasive Pneumothorax Detector $ 244,479.25  
Polgenix Inc Two Photon Opthalmascope $ 108,557.48 $ 42,361.15
Portal Capital LLC Prophylactic Therapies for Diseases with Airborne Transmission Vectors $ 61,027.82 $ 111,375.00
Preciss (DBA Language Access Network, LLC) Increasing Language Access in Clinical Environments $ 222,413.39 $ 22,065.86
RhinoSystems Inc Navage Nasal Hygiene Clinical Test   $ 25,000.00
Sonogage Inc Serial Tonometer for measurement of intraocular pressure $ 73,549.73 $ 170,929.52
Surgical Energetics, Inc FiberSecure wound closure device   $ 50,000.00
Syncro Medical Innovations, Inc. Development of a Tracheal Avoidance Feeding Tube with Bedside Confirmation $ 244,479.25  
Technology Medical Partners, L.L.C. Quality of Care Management System $ 11,433.95 $ 93,774.17
Tersus Pharmaceuticals Commercial Development of Provinal ™   $ 244,479.24
The Daavlin Distributing Company Staph Therapeutic Deliverly System $ 4,889.50 $ 12,731.50
The Utopia Group, LLC Joey Spray Guard Delivery System $ 88,082.69 $ 156,396.56
TheraVasc Inc. Treatment of Peripheral Artery Disease and Diabetic Ischemic Leg Problems with TV1001 $ 17,562.50 $ 226,916.75
Thermalin Diabetes Incorporated Development of Next Generation Insulin Analogs - 1 $ 11,538.39 $ 67,582.71
Thermalin Diabetes, LLC Development of Next Generation Insulin Analogs - 2   $ 244,479.24
Vertebration Inc Xycor Spinal Implant for Minimally Invasive Spine Surgery $ 244,479.25  
ViewRay Incorporated The ViewRay Renaissance™ real-time image-guided radiation therapy system $ 244,479.25  
ZIN Technologies, Inc. Vmetrics    $ 37,370.25
Page Last Reviewed or Updated: 26-Mar-2014